Medigen Vaccine (Taiwan) Today
| 6547 Stock | TWD 38.50 0.20 0.52% |
Performance0 of 100
| Odds Of DistressLess than 9
|
Medigen Vaccine is selling for under 38.50 as of the 26th of November 2024; that is 0.52 percent up since the beginning of the trading day. The stock's lowest day price was 38.15. Medigen Vaccine has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Medigen Vaccine Biologics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of October 2024 and ending today, the 26th of November 2024. Click here to learn more.
Medigen Vaccine Biologics Corporation, a biotechnology drug company, focuses on the development and production of vaccines and biologics in Taiwan and internationally. Medigen Vaccine Biologics Corporation is a subsidiary of Medigen Biotechnology Corp. The company has 327.2 M outstanding shares. More on Medigen Vaccine Biologics
Moving together with Medigen Stock
Moving against Medigen Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Medigen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Medigen Vaccine's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Medigen Vaccine or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Healthcare (View all Sectors) |
Medigen Vaccine Biologics (6547) is traded on Taiwan OTC Exchange in Taiwan and employs 16 people. The company currently falls under 'Large-Cap' category with a current market capitalization of 23.36 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medigen Vaccine's market, we take the total number of its shares issued and multiply it by Medigen Vaccine's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Medigen Vaccine Biologics operates under Healthcare sector and is part of Biotechnology industry. The entity has 327.2 M outstanding shares.
Medigen Vaccine Biologics has accumulated about 2.12 B in cash with 579.89 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 9.95.
Check Medigen Vaccine Probability Of Bankruptcy
Ownership AllocationMedigen Vaccine Biologics maintains a total of 327.2 Million outstanding shares. Medigen Vaccine Biologics holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Medigen Ownership Details
Medigen Vaccine Biologics Risk Profiles
Although Medigen Vaccine's alpha and beta are two of the key measurements used to evaluate Medigen Vaccine's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.12 | |||
| Standard Deviation | 1.44 | |||
| Variance | 2.08 | |||
| Risk Adjusted Performance | (0.18) |
Medigen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Medigen Vaccine without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Additional Tools for Medigen Stock Analysis
When running Medigen Vaccine's price analysis, check to measure Medigen Vaccine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medigen Vaccine is operating at the current time. Most of Medigen Vaccine's value examination focuses on studying past and present price action to predict the probability of Medigen Vaccine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medigen Vaccine's price. Additionally, you may evaluate how the addition of Medigen Vaccine to your portfolios can decrease your overall portfolio volatility.